David Krempa - Chief Business Officer at Eton Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Stock Symbol
ETON on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Krempa since 11/9/2023

Holdings reported by David Krempa for Eton Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 861K $4.09M $4.75 Oct 2, 2024 Direct Common Stock
Stock Option (Right to buy) 813K Feb 13, 2024 Direct Common Stock

Transactions reported by David Krempa for Eton Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.